PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.\', \'Division of Infectious Diseases, Brigham and Women\'s Hospital, Boston, Massachusetts, USA.\', \'Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.\', \'Emory University School of Medicine, Atlanta, Georgia, USA.\', \'Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.\', \'Department of Biology, Emory University, Atlanta, Georgia, USA.\', \'Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, Massachusetts, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciaa1704
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33161424
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of 2 Large Metropolitan Centers in the United States.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all